Synapse - Craig Moskowitz

Results (407)

Bendamustine is highly active in heavily pre-treated relapsed and refractory Hodgkin lymphoma and serves as a bridge to allogeneic stem cell transplant

Meeting Abstract

Moskowitz, A. J.; Hamlin, P. A.; Gerecitano, J.; Horwitz, S. M.; Matasar, M.; Meikle, J.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; more...
Blood (2009)

Fulltext@MSK | Save

A phase 1b clinical trial of dacetuzumab in combination with rituximab and gemcitabine: Multiple responses observed in patients with relapsed diffuse large B-cell lymphoma

Meeting Abstract

Forero-Torres, A.; Bartlett, N. L.; Nasta, S. D.; Northfelt, D.; Beaven, A.; Myint, H.; Whiting, N. C.; Drachman, J. G.; Moskowitz, C. H.
Blood (2009)

Fulltext@MSK | Save

Accelerated total lymphoid irradiation (TLI)-containing salvage regimen for patients with refractory and relapsed Hodgkin lymphoma (HL): 20 years outcome with multivariate analysis

Meeting Abstract

Rimner, A.; Bonner, P.; Gonzales, A. M. R.; Hsu, M.; Zhang, Z.; Moskowitz, C. H.; Yahalom, J.
EJC Supplements (2009)

Fulltext@MSK | Save

Accelerated total lymphoid irradiation (TLI) as an integral component of high-dose therapy (HDT) salvage regimen for patients with refractory and relapsed Hodgkin lymphoma (HL): 20 years of experience with 186 patients

Meeting Abstract

Rimner, A.; Bonner, P.; Gonzales, A. M. R.; Hsu, M.; Zhang, Z.; Moskowitz, C. H.; Yahalom, J.
International Journal of Radiation Oncology, Biology, Physics (2009)

Fulltext@MSK | Save

Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies

Journal Article

O'Connor, O. A.; Horwitz, S.; Hamlin, P.; Portlock, C.; Moskowitz, C. H.; Sarasohn, D.; Neylon, E.; Mastrella, J.; Hamelers, R.; Macgregor-Cortelli, B.; more...
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Expression of cytotoxic T cells in relapsed/refractory Hodgkin lymphoma

Meeting Abstract

Koreishi, A. F.; Persky, D. O.; Cui, H.; Moskowitz, A.; Moskowitz, C.; Teruya-Feldstein, J.
Modern Pathology (2009)

Fulltext@MSK | Save

CD5 negative, cyclin D1-positive diffuse large B-cell lymphoma (DLBCL) presenting as ruptured spleen

Journal Article

Teruya-Feldstein, J.; Gopalan, A.; Moskowitz, C. H.
Applied Immunohistochemistry & Molecular Morphology (2009)

Fulltext@MSK | Save

Pertussis Immunity and Response to Tetanus-Reduced Diphtheria-Reduced Pertussis Vaccine (Tdap) after Autologous Peripheral Blood Stem Cell Transplantation

Journal Article

Small, T. N.; Zelenetz, A. D.; Noy, A.; Rice, R. D.; Trippett, T. M.; Abrey, L.; Portlock, C. S.; Mccullagh, E. J.; Vanak, J. M.; Mulligan, A. M.; more...
Biology of Blood and Marrow Transplantation (2009)

Fulltext@MSK | Save

Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: Results of a multicentre phase 2 clinical trial

Journal Article

O'Connor, O. A.; Moskowitz, C.; Portlock, C.; Hamlin, P.; Straus, D.; Dumitrescu, O.; Sarasohn, D.; Gonen, M.; Butos, J.; Neylon, E.; more...
British Journal of Haematology (2009)

Fulltext@MSK | Save

Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma

Journal Article

Moskowitz, A. J.; Perales, M. A.; Kewalramani, T.; Yahalom, J.; Castro-Malaspina, H.; Zhang, Z.; Vanak, J.; Zelenetz, A. D.; Moskowitz, C. H.
British Journal of Haematology (2009)

Fulltext@MSK | Save